| drl | Stage | Hours | ZFIN expression range | forerunner cell group | anterior axial hypoblast | ventral mesoderm | lateral mesoderm | lateral plate mesoderm | hematopoietic system | anterior lateral mesoderm | posterior lateral mesoderm | rostral blood island | macrophage | intermediate cell mass of mesoderm | whole organism | unspecified |
| Zygote | 1-cell | 0 | ||||||||||||||
| Cleavage | 2-cell | 0.75 | ||||||||||||||
| 4-cell | 1.0 | |||||||||||||||
| 8-cell | 1.25 | |||||||||||||||
| 16-cell | 1.5 | |||||||||||||||
| 32-cell | 1.75 | |||||||||||||||
| 64-cell | 2.0 | |||||||||||||||
| Blastula | 124-cell | 2.25 | ||||||||||||||
| 256-cell | 2.5 | |||||||||||||||
| 512-cell | 2.75 | |||||||||||||||
| 1k-cell | 3.0 | |||||||||||||||
| High | 3.33 | |||||||||||||||
| Oblong | 3.66 | |||||||||||||||
| Sphere | 4.0 | |||||||||||||||
| Dome | 4.33 | |||||||||||||||
| 30% epiboly | 4.66 | |||||||||||||||
| Gastrula | 50%-epiboly | 5.25 | ! | ! | ||||||||||||
| Germ-ring | 5.66 | ! | ! | |||||||||||||
| Shield | 6.0 | ! | ! | |||||||||||||
| 75% epiboly stage | 8.0 | |||||||||||||||
| 90% epiboly | 9.0 | I | ||||||||||||||
| bud stage | 10.0 | |||||||||||||||
| Segmentation | 1-4 somites | 10.33 | I | |||||||||||||
| 5-9 somites | 11.66 | I | I | |||||||||||||
| 10-13 somites | 14.0 | |||||||||||||||
| 14-19 somites | 16.0 | I | ||||||||||||||
| 20-25 somites | 19.0 | |||||||||||||||
| 26+ somites | 22.0 | I | ||||||||||||||
| Pharyngula | Prim-5 | 24.0 | ||||||||||||||
| Prim-15 | 30.0 | X | ||||||||||||||
| Prim-25 | 36.0 | X | ||||||||||||||
| High-pec | 42.0 | X | ||||||||||||||
| Hatching | Long-pec | 48.0 | X | |||||||||||||
| Pec-fin | 60.0 |
| Evidence for Interaction | dra is reduced in tbx16 mutant at 70% epiboly stage. |
| Target Gene | drl |
| Upstream Gene | tbx16 |
| Interaction Type | enhance |
| Altered model | mutant embryos |
| Time of Interaction in evidence | 8 |
| Location of Interaction in evidence | mesendoderm |
| Evidence for Direct | 1 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Robert K. Ho |
| Journal | Developmental Cell |
| Year | 2004 |
| Vol | 7 |
| Start Page | 251 |
| Evidence for Interaction | drl expression domain absent at Bud through 12s in the tbx16 mutant. |
| Target Gene | drl |
| Upstream Gene | tbx16 |
| Interaction Type | enhance |
| Altered model | mutant embryos |
| Time of Interaction in evidence | 8 |
| Location of Interaction in evidence | paraxil mesoderm |
| Evidence for Direct | 1 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Robert K. Ho |
| Journal | Developmental Cell |
| Year | 2004 |
| Vol | 7 |
| Start Page | 251 |
| Evidence for Interaction | dra is absent in tbx16 mutant at Bud stage |
| Target Gene | drl |
| Upstream Gene | tbx16 |
| Interaction Type | enhance |
| Altered model | mutant embryos |
| Time of Interaction in evidence | 10 |
| Location of Interaction in evidence | paraxil mesoderm |
| Evidence for Direct | 1 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Robert K. Ho |
| Journal | Developmental Cell |
| Year | 2004 |
| Vol | 7 |
| Start Page | 251 |
| Evidence for Interaction | Expression of drl was lost in most of the PLM by 10 somites (14 hpf) in tal1 MO-injected embryos. |
| Target Gene | drl |
| Upstream Gene | tal1 |
| Interaction Type | enhance |
| Altered model | MASO |
| Time of Interaction in evidence | 14 |
| Location of Interaction in evidence | blood |
| Evidence for Direct | 3 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Roger Patient |
| Journal | blood |
| Year | 2005 |
| Vol | 105 |
| Start Page | 9 |
| Evidence for Interaction | drl expression was lost in most of the PLM by 10 somites in MO-injected embryos. |
| Target Gene | drl |
| Upstream Gene | tal1 |
| Interaction Type | enhance |
| Altered model | MASO |
| Time of Interaction in evidence | 14 |
| Location of Interaction in evidence | blood precursors |
| Evidence for Direct | 3 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Roger Patient |
| Journal | blood |
| Year | 2005 |
| Vol | 105 |
| Start Page | 9 |
| Evidence for Interaction | drl expression domain absent at Bud through 12s in the tbx16 mutant. |
| Target Gene | drl |
| Upstream Gene | tbx16 |
| Interaction Type | enhance |
| Altered model | mutant embryos |
| Time of Interaction in evidence | 14 |
| Location of Interaction in evidence | paraxil mesoderm |
| Evidence for Direct | 1 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Robert K. Ho |
| Journal | Developmental Cell |
| Year | 2004 |
| Vol | 7 |
| Start Page | 251 |
| Evidence for Interaction | dra is absent in tbx16 mutant at 12 somite stage. |
| Target Gene | drl |
| Upstream Gene | tbx16 |
| Interaction Type | enhance |
| Altered model | mutant embryos |
| Time of Interaction in evidence | 14 |
| Location of Interaction in evidence | paraxil mesoderm |
| Evidence for Direct | 1 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Robert K. Ho |
| Journal | Developmental Cell |
| Year | 2004 |
| Vol | 7 |
| Start Page | 251 |
| Evidence for Interaction | drl expression domain absent at Bud through 12s in the tbx16 mutant. |
| Target Gene | drl |
| Upstream Gene | tbx16 |
| Interaction Type | enhance |
| Altered model | mutant embryos |
| Time of Interaction in evidence | 14 |
| Location of Interaction in evidence | tailbud |
| Evidence for Direct | 1 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Robert K. Ho |
| Journal | Developmental Cell |
| Year | 2004 |
| Vol | 7 |
| Start Page | 251 |
| Evidence for Interaction | dra is absent in tbx16 mutant at 12 somite stage. |
| Target Gene | drl |
| Upstream Gene | tbx16 |
| Interaction Type | enhance |
| Altered model | mutant embryos |
| Time of Interaction in evidence | 14 |
| Location of Interaction in evidence | tailbud |
| Evidence for Direct | 1 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Robert K. Ho |
| Journal | Developmental Cell |
| Year | 2004 |
| Vol | 7 |
| Start Page | 251 |